105 related articles for article (PubMed ID: 11994678)
1. Neuroendocrine and metabolic determinants of the adaptation of GH/IGF-I axis to obesity.
Maccario M; Tassone F; Grottoli S; Rossetto R; Gauna C; Ghigo E
Ann Endocrinol (Paris); 2002 Apr; 63(2 Pt 1):140-4. PubMed ID: 11994678
[TBL] [Abstract][Full Text] [Related]
2. Effects of 36 hour fasting on GH/IGF-I axis and metabolic parameters in patients with simple obesity. Comparison with normal subjects and hypopituitary patients with severe GH deficiency.
Maccario M; Aimaretti G; Grottoli S; Gauna C; Tassone F; Corneli G; Rossetto R; Wu Z; Strasburger CJ; Ghigo E
Int J Obes Relat Metab Disord; 2001 Aug; 25(8):1233-9. PubMed ID: 11477509
[TBL] [Abstract][Full Text] [Related]
3. Hypothalamic growth hormone-insulin-like growth factor-I axis across the human life span.
Ghigo E; Arvat E; Gianotti L; Lanfranco F; Broglio F; Aimaretti G; Maccario M; Camanni F
J Pediatr Endocrinol Metab; 2000; 13 Suppl 6():1493-502. PubMed ID: 11202226
[TBL] [Abstract][Full Text] [Related]
4. Effects of recombinant human insulin-like growth factor I administration on the growth hormone (gh) response to GH-releasing hormone in obesity.
Maccario M; Tassone F; Gianotti L; Lanfranco F; Grottoli S; Arvat E; Muller EE; Ghigo E
J Clin Endocrinol Metab; 2001 Jan; 86(1):167-71. PubMed ID: 11231996
[TBL] [Abstract][Full Text] [Related]
5. Polysomnographic sleep, growth hormone insulin-like growth factor-I axis, leptin, and weight loss.
Rasmussen MH; Wildschiødtz G; Juul A; Hilsted J
Obesity (Silver Spring); 2008 Jul; 16(7):1516-21. PubMed ID: 18464752
[TBL] [Abstract][Full Text] [Related]
6. GH/IGF-I axis in anorexia nervosa.
Gianotti L; Lanfranco F; Ramunni J; Destefanis S; Ghigo E; Arvat E
Eat Weight Disord; 2002 Jun; 7(2):94-105. PubMed ID: 17644863
[TBL] [Abstract][Full Text] [Related]
7. Metabolic regulation of the neuroendocrine axis in pigs.
Barb CR; Kraeling RR; Rampacek GB
Reprod Suppl; 2002; 59():203-17. PubMed ID: 12698983
[TBL] [Abstract][Full Text] [Related]
8. Human aging and the GH-IGF-I axis.
Ghigo E; Arvat E; Gianotti L; Ramunni J; DiVito L; Maccagno B; Grottoli S; Camanni F
J Pediatr Endocrinol Metab; 1996 Jun; 9 Suppl 3():271-8. PubMed ID: 8887170
[TBL] [Abstract][Full Text] [Related]
9. Examination of the direct effects of metabolic factors on somatotrope function in a non-human primate model, Papio anubis.
Luque RM; Gahete MD; Valentine RJ; Kineman RD
J Mol Endocrinol; 2006 Aug; 37(1):25-38. PubMed ID: 16901921
[TBL] [Abstract][Full Text] [Related]
10. Massive weight loss restores 24-hour growth hormone release profiles and serum insulin-like growth factor-I levels in obese subjects.
Rasmussen MH; Hvidberg A; Juul A; Main KM; Gotfredsen A; Skakkebaek NE; Hilsted J; Skakkebae NE
J Clin Endocrinol Metab; 1995 Apr; 80(4):1407-15. PubMed ID: 7536210
[TBL] [Abstract][Full Text] [Related]
11. Lack of stimulation of 24-hour growth hormone release by hypocaloric diet in obesity.
Rasmussen MH; Juul A; Kjems LL; Skakkebaek NE; Hilsted J
J Clin Endocrinol Metab; 1995 Mar; 80(3):796-801. PubMed ID: 7533771
[TBL] [Abstract][Full Text] [Related]
12. Multiple endocrine abnormalities of the growth hormone and insulin-like growth factor axis in prepubertal children with exogenous obesity: effect of short- and long-term weight reduction.
Argente J; Caballo N; Barrios V; Pozo J; Muñoz MT; Chowen JA; Hernández M
J Clin Endocrinol Metab; 1997 Jul; 82(7):2076-83. PubMed ID: 9215275
[TBL] [Abstract][Full Text] [Related]
13. Basal and growth hormone-induced hepatic messenger ribonucleic acid expression of insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 is independent of hyperinsulinemia and increased energy status in the genetically obese Zucker rat.
Melián E; Velasco B; Barrios R; Sanchez-Franco F
Endocrinology; 1997 Mar; 138(3):1066-71. PubMed ID: 9048610
[TBL] [Abstract][Full Text] [Related]
14. Modulation of circulating IGF-I and IGFBP-3 levels by hormonal regulators of energy homeostasis in obese children.
Woelfle JF; Harz K; Roth C
Exp Clin Endocrinol Diabetes; 2007 Jan; 115(1):17-23. PubMed ID: 17286229
[TBL] [Abstract][Full Text] [Related]
15. A transgenic model to determine the physiological role of liver-derived insulin-like growth factor I.
Sjögren K; Jansson JO; Isaksson OG; Ohlsson C
Minerva Endocrinol; 2002 Dec; 27(4):299-311. PubMed ID: 12511852
[TBL] [Abstract][Full Text] [Related]
16. The endocrine response to acute ghrelin administration is blunted in patients with anorexia nervosa, a ghrelin hypersecretory state.
Broglio F; Gianotti L; Destefanis S; Fassino S; Abbate Daga G; Mondelli V; Lanfranco F; Gottero C; Gauna C; Hofland L; Van der Lely AJ; Ghigo E
Clin Endocrinol (Oxf); 2004 May; 60(5):592-9. PubMed ID: 15104562
[TBL] [Abstract][Full Text] [Related]
17. Secretagogues and the somatotrope: signaling and proliferation.
Frohman LA; Kineman RD; Kamegai J; Park S; Teixeira LT; Coschigano KT; Kopchic JJ
Recent Prog Horm Res; 2000; 55():269-90; discussion 290-1. PubMed ID: 11036941
[TBL] [Abstract][Full Text] [Related]
18. Effects of oral versus transdermal estrogen on the growth hormone/insulin-like growth factor I axis in younger and older postmenopausal women: a clinical research center study.
Bellantoni MF; Vittone J; Campfield AT; Bass KM; Harman SM; Blackman MR
J Clin Endocrinol Metab; 1996 Aug; 81(8):2848-53. PubMed ID: 8768841
[TBL] [Abstract][Full Text] [Related]
19. Regulation of the growth hormone-insulin-like growth factor I axis in developing and adult monkeys is affected by estradiol replacement and supplementation with insulin-like growth factor I.
Wilson ME
J Clin Endocrinol Metab; 1998 Jun; 83(6):2018-28. PubMed ID: 9626134
[TBL] [Abstract][Full Text] [Related]
20. Expression analysis of hypothalamic and pituitary components of the growth hormone axis in fasted and streptozotocin-treated neuropeptide Y (NPY)-intact (NPY+/+) and NPY-knockout (NPY-/-) mice.
Park S; Peng XD; Frohman LA; Kineman RD
Neuroendocrinology; 2005; 81(6):360-71. PubMed ID: 16244497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
